SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

03 May, 2008

 

 

PROTHERICS PLC

(Translation of Registrant’s Name Into English)

 

 

The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F       X              Form 40-F               

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):             

 

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes                     No          X     

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-              .

 

 

The Registrant is furnishing a copy of its announcements as reported to the Company Announcements Office of the London Stock Exchange.

 

 

 

Protherics PLC

Director Share Purchases


London, UK; Brentwood, TN; 
3 June 2008
 -
 
Protherics PLC (
"Protherics
"
 or 
the 
"
Company"
), the international biopharmaceutical company focused on critical care and cancer, 
announces that
 
today
, i
n accordance 
with paragraph 3.1.2 of 
the 
FSA 
Disclosure and Transparency Rules, the Company received notification 
of the following dealings 
in the Ordinary share capital of the Company (Ordinary 2p Shares) 
by Directors and other Persons Discharging Managerial Responsibility (PDMRs)
,
 which took place
 
on 3 June 2008
:

Director:
Position
Number of Ordinary 2p Shares acquired
% of issued share capital
Price paid per share (p)
Andrew Heath
Chief Executive
30,000
0.009
38.0
Rolf Soderstrom
Finance Director
20,000
0.006
38.0





PDMR:




Nick Staples
Director of Corporate Affairs
13,066
0.004
38.0




Following the above 
transaction
s, the
ir interests in the Ordinary Shares of the Company are 
as follows:


Number of Ordinary 2p Shares

% of 
issued share
 capital
Andrew Heath
  419,810
0.124
Rolf Soderstrom
  20,000
0.006
Nick Staples
  13,066
0.004



The Company's issued ordinary share
 capital is 339,222,905
 shares.

| Ends |

F
or f
urther 
i
nformation
 please contact
:

Protherics 

Nick Staples
, 
Director of Corporate 
Affairs
+44 (0) 7919 480510  
Julie Vickers, Company Secretary 
    
+44 (0)
1928 51801
0


Financial Dynamics
 
- press enquiries

London:
 Ben Atwell, Lara Mott
+44 (0) 20 7831 3113 
New York
:
 John Capodanno, 
Jonathan Birt
+1 212 850 5600



Or visi
t  
www.protherics.com
 
 
 
 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       

 

PROTHERICS PLC

       

Date: 03 May, 2008

 

By:

 

/s/ Rolf Soderstrom

       

Rolf Soderstrom

       

Finance Director

 

 

Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Protherics Charts.
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Protherics Charts.